Frontage Laboratories has appointed Dr. Cheryl Li senior vice president, Global CMC Services. The division offers an integrated service portfolio ranging from dosage form product development, contract manufacturing, pharmaceutical analysis and organic syntheses to CMC strategy consulting. Li’s position is an initial step of Frontage’s corporate strategic expansion in CMC infrastructure to meet growing development needs in novel drugs, generic products and biosimilars.
Previously, Li held several management positions at Johnson & Johnson Consumer Group, most recently as director, global innovation sourcing and strategic partnership, where she led growth initiatives involving product and process technologies for OTC, health and nutrition, skin, oral and personal care businesses. Previously, she was director of technical operations at Mallinckrodt Baker/Covidien and led product development groups at Albany Molecular Research Inc. and Honeywell.